Schedule 13G ownership disclosure
Voyager Therapeutics Inc
Security class unavailable · CUSIP: 92915B106
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-042298
- Form type
- SC 13G
- Filer
- UBS Group AG
- CIK
- CIK 1610520
- Filed
- Feb 15, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership